Flagship Pioneering Forms Etcelera to Advance Causal Intelligence in Drug Discovery
· GlobeWire Daily Business Desk · Source: www.prnewswire.com

Original GlobeWire Daily editorial illustration — not an event photograph.
Flagship Pioneering announced the formation of Etcelera, a new company created by merging the platforms of Cellarity, Etiome, and Empress Therapeutics alongside Flagship's proprietary artificial intelligence capabilities. The newly formed entity aims to scale causal intelligence in human biology, shifting drug discovery from empirical probability to predictive science.
Key Integration and Leadership
- Unified Platforms: Etcelera integrates high-resolution human transcriptomic data, advanced chemoproteomics, and state-of-the-art perturbation data generation.
- Executive Leadership: Ad Rawcliffe, a veteran CEO and Flagship Pioneering CEO-Partner, will lead the new organization as Chief Executive Officer.
- Board Oversight: Alec Reynolds, Senior Partner at Flagship Pioneering, serves as Chairman of the Board.
Technological Foundation and Initial Focus
The unified platform builds upon years of innovation originating within Flagship Labs. By combining Cellarity's whole-cell state insights, Etiome's temporal disease-stage intelligence, and Empress Therapeutics' industrialized multi-omics technology with an industry foundation model trained on data from 150 million cells, Etcelera seeks to decode cause-and-effect relationships at the molecular level.
At launch, the company's pipeline includes programs across several therapeutic areas:
- Hematology: Programs addressing myelofibrosis and essential thrombocythemia.
- Metabolism: Initiatives featuring partnered programs in MASH (Metabolic dysfunction-associated steatohepatitis).
- Immunology: Exploratory and foundational development programs.
Practical Implications and Verification
Etcelera's approach aims to address high failure rates in clinical trials by utilizing AI-powered prediction models before clinical testing. Stakeholders and industry observers can review official announcements and organizational updates directly through Flagship Pioneering or the official corporate website at www.etcelera.com.
AI-assisted reporting; source claims are attributed and have not been independently verified.



